AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
FIRST LINE HIGH-DOSE CHEMOTHERAPY WITH PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ADVANCED CLL (BINET STAGE B-C) - RESULTS OF A PROSPECTIVE PHASE-II STUDY
Authors: LINASSIER C CAHN JY DESABLENS B SENSEBE L VILQUE JP WITZ F COMBE M LUTHIER F DECONNINCK E MALIVOIR B COLOMBAT P
Citation: C. Linassier et al., FIRST LINE HIGH-DOSE CHEMOTHERAPY WITH PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ADVANCED CLL (BINET STAGE B-C) - RESULTS OF A PROSPECTIVE PHASE-II STUDY, Bone marrow transplantation, 21, 1998, pp. 269-269
BONE-MARROW RECOVERY AFTER AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION - ROLE OF POSTTHAWING PARAMETERS
Authors: FEUGIER P SCHUHMACHER A GIRARD F ALLA F BENSOUSSAN D LATGER V WITZ F CARRET AS BORDIGONI P JANOT C
Citation: P. Feugier et al., BONE-MARROW RECOVERY AFTER AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION - ROLE OF POSTTHAWING PARAMETERS, British Journal of Haematology, 102(1), 1998, pp. 68-68
ADDITION OF SCF TO CHEMOTHERAPY AND FILGRASTIM MOBILIZATION MAY ENABLE PROGENITOR SUPPORT TO BE GIVEN IN THE FORM OF WHOLE-BLOOD INFUSIONS
Authors: VILLARD F BOHBOT A BOUZGARROU R CALOT JP FEUGIER P GIRAUD C MALOISEL F REIFFERS J ATTAL M WITZ F GUILHOT F HAROUSSEAU JL MUR M MERESSE V CARAUX J FACON T
Citation: F. Villard et al., ADDITION OF SCF TO CHEMOTHERAPY AND FILGRASTIM MOBILIZATION MAY ENABLE PROGENITOR SUPPORT TO BE GIVEN IN THE FORM OF WHOLE-BLOOD INFUSIONS, British Journal of Haematology, 102(1), 1998, pp. 72-72
G-CSF AFTER INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) IN ACUTE MYELOID-LEUKEMIA (AML)
Authors: HAROUSSEAU JL WITZ F LIOURE B LEPRISE PY SOLARY E ABGRALL JF CASSASUS P AUDHUY B TRAVADE P CAHN JY
Citation: Jl. Harousseau et al., G-CSF AFTER INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) IN ACUTE MYELOID-LEUKEMIA (AML), British Journal of Haematology, 102(1), 1998, pp. 86-86
A PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ADMINISTERED DURING AND AFTER INDUCTION TREATMENT FOR DE-NOVO ACUTE MYELOGENOUS LEUKEMIA IN ELDERLY PATIENTS
Authors: WITZ F SADOUN A PERRIN MC BERTHOU C BRIERE J CAHN JY LIOURE B WITZ B FRANCOIS S DESABLENS B PIGNON B LEPRISE PY AUDHUY B CAILLOT D CASASSUS P DELAIN M CHRISTIAN B TELLIER Z POLIN V HURTELOUP P HAROUSSEAU JL
Citation: F. Witz et al., A PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ADMINISTERED DURING AND AFTER INDUCTION TREATMENT FOR DE-NOVO ACUTE MYELOGENOUS LEUKEMIA IN ELDERLY PATIENTS, Blood, 91(8), 1998, pp. 2722-2730
HETEROGENOUS EXPRESSION OF CD15 IN ACUTE LYMPHOBLASTIC-LEUKEMIA - A STUDY OF 10 ANTI-CD15 MONOCLONAL-ANTIBODIES IN 158 PATIENTS
Authors: MAYNADIE M CAMPOS L MOSKOVTCHENKO P SABIDO O AHO S LENORMAND B CARLI PM GUYOTAT D BENE MC FAURE G CAPIOD JC GARDAIS J FEUILLARD J RAPHAEL M LACOMBE R LECALVEZ G LEGLISE MC DENEYS V MASSON AM BERNIER M MALET AM SALAUN C BOURIN P RAPATEL C TAVERNIER F JOUAULT H LELONG F CHRETIEN P SOLARY E CASASNOVAS RO MAYNADIE M MOSKOVTCHENKO P FAVRE M BENSA JC JACOB MC WALLEF G SARIAUX C TRIMOREAU F PRALORAN V CAMPOS L SABIDO O VASSELON C BRUNET C PONCELET P GUITARD AM TAIB J LAVABREBERTRAND T JUNG G KANDEL G GARAND R PHILIP P SUDAKA I MONPOUX F VANHAEKE D PERROT JY MARIE JP VALENSI F VERGE V HOMBERG JC SCHAISON G BOUMSELL L DOUAY L SAMSON T BRIZARD A DALIPHARD S DRENOU B LEES O LENORMAND B POILANE B FALKENRODT A ALBERT A KUHLEIN E ESTIENNE MH BREMOND JL DEGENNE M LEBARON F REUMAUX G DUTHILLEUL P BENE MC FAURE G BORDIGONI P WITZ F KOLLOPSARDA MN BAYLE C ANTONINI J BOUCHEIX C CHARPENTIER A
Citation: M. Maynadie et al., HETEROGENOUS EXPRESSION OF CD15 IN ACUTE LYMPHOBLASTIC-LEUKEMIA - A STUDY OF 10 ANTI-CD15 MONOCLONAL-ANTIBODIES IN 158 PATIENTS, Leukemia & lymphoma, 25(1-2), 1997, pp. 135-143
DONOR SEARCH OR AUTOGRAFTING IN PATIENTS WITH ACUTE-LEUKEMIA WHO LACKAN HLA-IDENTICAL SIBLING - A MATCHED-PAIR ANALYSIS
Authors: RINGDEN O LABOPIN M GLUCKMAN E HOWS JM BRADLEY BA KOLB HJ FOUILLARD L JACOBSEN N VERNANT JP WITZ F HAROUSSEAU JL GORIN NC
Citation: O. Ringden et al., DONOR SEARCH OR AUTOGRAFTING IN PATIENTS WITH ACUTE-LEUKEMIA WHO LACKAN HLA-IDENTICAL SIBLING - A MATCHED-PAIR ANALYSIS, Bone marrow transplantation, 19(10), 1997, pp. 963-968
HEPATIC-ABSCESS DUE TO STREPTOCOCCUS-MILL ERI
Authors: HULIN C GUERCI A DORVAUX V RABY P FEUGIER P WITZ F LEDERLIN P
Citation: C. Hulin et al., HEPATIC-ABSCESS DUE TO STREPTOCOCCUS-MILL ERI, La Revue de medecine interne, 18, 1997, pp. 340-341
AVASCULAR NECROSIS OF BONE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - ANALYSIS OF RISK-FACTORS FOR 4388 PATIENTS BY THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE (SFGM)
Authors: SOCIE G CAHN JY CARMELO J VERNANT JP JOUET JP IFRAH N MILPIED N MICHALLET M LIOURE B PICO JL WITZ F MOLINA L FISCHER A BARDOU VJ GLUCKMAN E REIFFERS J
Citation: G. Socie et al., AVASCULAR NECROSIS OF BONE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - ANALYSIS OF RISK-FACTORS FOR 4388 PATIENTS BY THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE (SFGM), British Journal of Haematology, 97(4), 1997, pp. 865-870
COMPARISON OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND INTENSIVE CHEMOTHERAPY AS POSTREMISSION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA
Authors: HAROUSSEAU JL CAHN JY PIGNON B WITZ F MILPIED N DELAIN M LIOURE B LAMY T DESABLENS B GUILHOT F CAILLOT D ABGRALL JF FRANCOIS S BRIERE J GUYOTAT D CASASSUS P AUDHUY B TELLIER Z HURTELOUP P HERVE P
Citation: Jl. Harousseau et al., COMPARISON OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND INTENSIVE CHEMOTHERAPY AS POSTREMISSION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA, Blood, 90(8), 1997, pp. 2978-2986
COST-EFFECTIVENESS ANALYSIS OF GOELAM SA3, A RANDOMIZED PLACEBO-CONTROLLED PROTOCOL OF GM-SCF FOR ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA
Authors: WORONOFFLEMSI MC DEMOLY P ARVEUX P IFRAH N TELLIER Z HAROUSSEAU JL CAHN JY WITZ F
Citation: Mc. Woronofflemsi et al., COST-EFFECTIVENESS ANALYSIS OF GOELAM SA3, A RANDOMIZED PLACEBO-CONTROLLED PROTOCOL OF GM-SCF FOR ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA, Blood, 90(10), 1997, pp. 313-313
FIRST LINE HIGH-DOSE CHEMOTHERAPY WITH PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ADVANCED CLL (BINET STAGE B-C) - RESULTS OF A PROSPECTIVE PHASE-II STUDY
Authors: LINASSIER C CAHN JY DESABLENS B SENESEBE L VILQUE JP WITZ F COMBE M LUTHIER F DECONNINCK E MALIVOIR B COLOMBAT P
Citation: C. Linassier et al., FIRST LINE HIGH-DOSE CHEMOTHERAPY WITH PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ADVANCED CLL (BINET STAGE B-C) - RESULTS OF A PROSPECTIVE PHASE-II STUDY, Blood, 90(10), 1997, pp. 1030-1030
AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) REPRESENTS THE BEST CONSOLIDATION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML) IN 2ND COMPLETE REMISSION (CR) - A RETROSPECTIVE STUDY OF THE GOELAMS GROUP
Authors: LIOURE B WITZ F DECONNINCK E DELAIN M SOLARY E BERTHOU C AUDHUY B FRANCOIS S GUYOTAT D SADDOUN A PIGNON B HAROUSSEAU JL OBERLING F
Citation: B. Lioure et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) REPRESENTS THE BEST CONSOLIDATION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML) IN 2ND COMPLETE REMISSION (CR) - A RETROSPECTIVE STUDY OF THE GOELAMS GROUP, Blood, 90(10), 1997, pp. 1710-1710
G-CSF AFTER INTENSIVE CONSOLIDATION CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA (AML)
Authors: HAROUSSEAU JL WITZ F DESABLENS B LEPRISE PY FRANCOIS S DELAIN M ABGRALL JF SOLARY E
Citation: Jl. Harousseau et al., G-CSF AFTER INTENSIVE CONSOLIDATION CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA (AML), Blood, 90(10), 1997, pp. 2249-2249
TREATMENT OF ACUTE MYELOBLASTIC-LEUKEMIA IN ADULTS - THE GOELAM EXPERIENCE
Authors: HAROUSSEAU JL PIGNON B WITZ F POLIN V TELLIER Z HURTELOUP P CAHN JY
Citation: Jl. Harousseau et al., TREATMENT OF ACUTE MYELOBLASTIC-LEUKEMIA IN ADULTS - THE GOELAM EXPERIENCE, HEM CELL TH, 38(5), 1996, pp. 381-391
AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IS NOT SUPERIOR TO INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) FOR POSTREMISSION THERAPY IN ADULT ACUTE MYELOBLASTIC-LEUKEMIA (AML) - FINAL ANALYSIS OF THE GOELAMS STUDY
Authors: CAHN JY HAROUSSEAU JL PIGNON B WITZ F DELAIN M LIOURE B LAMY T SOLARY E DESABLENS B BRIERE J CASSASUS P AUDHUY B POLIN V HURTELOUP P TELLIER Z
Citation: Jy. Cahn et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IS NOT SUPERIOR TO INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) FOR POSTREMISSION THERAPY IN ADULT ACUTE MYELOBLASTIC-LEUKEMIA (AML) - FINAL ANALYSIS OF THE GOELAMS STUDY, Experimental hematology, 24(9), 1996, pp. 671-671
TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN PATIENTS AGED 50-65 - IDARUBICIN IS MORE EFFECTIVE THAN ZORUBICIN FOR REMISSION INDUCTION AND PROLONGED DISEASE-FREE SURVIVAL CAN BE OBTAINED USING A UNIQUE CONSOLIDATION COURSE
Authors: PIGNON B WITZ F DESABLENS B LEPRISE PY FRANCOIS S LINASSIER C BERTHOU C CAILLOT D LIOURE B CAHN JY CASASSUS P SADOUN A AUDHUY B GUYOTAT D BRIERE J VILQUE JP BARANGER L POLIN V BERTHAUD P HURTELOUP P HERVE P HAROUSSEAU JL
Citation: B. Pignon et al., TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN PATIENTS AGED 50-65 - IDARUBICIN IS MORE EFFECTIVE THAN ZORUBICIN FOR REMISSION INDUCTION AND PROLONGED DISEASE-FREE SURVIVAL CAN BE OBTAINED USING A UNIQUE CONSOLIDATION COURSE, British Journal of Haematology, 94(2), 1996, pp. 333-341
CYTOGENETIC ABNORMALITIES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATIONS WITH HEMATOLOGIC FINDINGS AND OUTCOME - A COLLABORATIVE STUDY OF THE GROUPE-FRANCAIS-DE-CYTOGENETIQUE-HEMATOLOGIQUE (VOL 87, PG 3135, 1996)
Authors: CHARRIN C MAGAUD JP SEBBAN C FIERE D DASTUGUE N HUGUETRIGAL F ATTAL M SIE P LAI JL JOUET JP SIMON M ZANDECKI M GREGOIRE MJ WITZ F WITZ B BARIN C MORAINE C MUGNERET F FAVRE B RAYNAUD S GRATECOS N THYSS A AYRAUD N LAFAGE M AMOULET C SAINTY D MOZZICONACCI MJ STOPPA AM BERNARD P REIFFERS J BARANGER L BOASSON M IFRAH N VANDENAKKER J PERROT C BERTHEAS MF VASSELON C CALMARD P GUYOTAT D TALMANT P UETTWILLER F MALOLSEL F RUCH JV OBERLING F WEH HJ VERELLENDUMOULIN C LIBOUTON JM DELANNOY A FERRANT A MICHAUX JL DESANGLES F RIVIERE D PLUCHONRIVIERE E BERTHOU C PEDRON MF NOEL B LESPINASSE J MECUCCI C VANDENBERGHE H BERGER R POLSSONNIER M NOEL L GARDIN C TURELURE P VERHEST A GIOLLANT M DOSSANTOS E TOUMILHAC O RAMOND S DREYFUS F ZITTOUN R SMADJA N KRULIK M SCHOENWALD M VAUGLER GL LEBLOND V HURET JL GIRAUD C TANZER J ECLACHE V CAPODANO AM ZATTARACANNONI H LEONARD C TCHERNIA G
Citation: C. Charrin et al., CYTOGENETIC ABNORMALITIES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATIONS WITH HEMATOLOGIC FINDINGS AND OUTCOME - A COLLABORATIVE STUDY OF THE GROUPE-FRANCAIS-DE-CYTOGENETIQUE-HEMATOLOGIQUE (VOL 87, PG 3135, 1996), Blood, 88(7), 1996, pp. 2818-2818
NEW ASSOCIATION OF HIGH-DOSE MITOXANTRONE (MTX), CARBOPLATIN (CBCDA) AND VP16 AS TREATMENT FOR RELAPSED OR REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML)
Authors: LIOURE B MOREAU P WITZ F WITZ B VILQUE JP FRANCOIS S BRION A DELAIN M CASASSUS P OJEDA M CAHN JY OBERLING F HAROUSSEAU JL
Citation: B. Lioure et al., NEW ASSOCIATION OF HIGH-DOSE MITOXANTRONE (MTX), CARBOPLATIN (CBCDA) AND VP16 AS TREATMENT FOR RELAPSED OR REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML), Blood, 88(10), 1996, pp. 848-848
FRONT-LINE OR RESCUE AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOLLOWING A FIRST COURSE OF HIGH-DOSE MELPHALAN (HDM) IN MULTIPLE-MYELOMA (MM) - PRELIMINARY-RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL (CIAM PROTOCOL)
Authors: FACON T MARY JY HAROUSSEAU JL ATTAL M BOSLY A MICHAUX JL MALOISEL F SADOUN A MURON T ANGLARET B ROSSI JF QUIQUANDON I DESABLENS B WITZ F BENBOUCKER L FOUSSARD C GARDEMBAS M PIGNON B GROSBOIS B MONCONDUIT M AUTRAND C CASASSUS P CAILLOT D GRATECOS N MAISONNEUVE H FABBRO M PIEL G MATHIEUBOUE A JOUET JP BATAILLE R
Citation: T. Facon et al., FRONT-LINE OR RESCUE AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOLLOWING A FIRST COURSE OF HIGH-DOSE MELPHALAN (HDM) IN MULTIPLE-MYELOMA (MM) - PRELIMINARY-RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL (CIAM PROTOCOL), Blood, 88(10), 1996, pp. 2729-2729
FACTORS INFLUENCING OUTCOME IN DE-NOVO MYELODYSPLASTIC SYNDROMES TREATED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION - A LONG-TERM STUDY OF 71 PATIENTS
Authors: SUTTON L CHASTANG C RIBAUD P JOUET JP KUENTZ M ATTAL M REIFFERS J TIGAUD JM RIO B DAURIAC C LEGROS M DREYFUS F LIOURE B TROUSSARD X MILPIED N WITZ F ORIOL P CAHN JY MICHALLET M GLUCKMAN E IFRAH N PICO JL VILMER E LEBLOND V
Citation: L. Sutton et al., FACTORS INFLUENCING OUTCOME IN DE-NOVO MYELODYSPLASTIC SYNDROMES TREATED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION - A LONG-TERM STUDY OF 71 PATIENTS, Blood, 88(1), 1996, pp. 358-365
CYTOGENETIC ABNORMALITIES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATIONS WITH HEMATOLOGIC FINDINGS AND OUTCOME - A COLLABORATIVE STUDY OF THE GROUPE-FRANCAIS-DE-CYTOGENETIQUE-HEMATOLOGIQUE
Authors: CHARRIN C MAGAUD JP SEBBAN C FIERE D DASTUGUE N HUGUETRIGAL F ATTAL M SIE P LAI JL JOUET JP SIMON M ZANDECKI M GREGOIRE MJ WITZ F WITZ B BARIN C MORAINE C MUGNERET F FAVRE B RAYNAUD S BAUDOIN F GRATECOS N THYSS A AYRAUD N LAFAGE M ARNOULET C SAINTY D MOZZICONACCI MJ STOPPA AM BERNARD P REIFFERS J VANDENAKKER J PERROT C BERTHEAS MF VASSELON C CALMARD P GUYOTAT D TALMANT P UETTWILLER F MALOISEL F RUCH JV OBERLING F WEH HJ VERELLENDUMOULIN C LIBOUTON JM DELANNOY A FERRANT A MICHAUX JL DESANGLES F RIVIERE D PLUCHONRIVIERE E BERTHOU C PEDRON MF NOEL B LESPINASSE J MECUCCI C VANDENBERGHE H BERGER R POISSONNIER M NOEL L GARDIN C TURELURE P VERHEST A GIOLLANT M DOSSANTOS E TOURNILHAC O RAMOND S DREYFUS F ZITTOUN R SMADJA N KRULIK M SCHOENWALD M VAUGIER GL LEBLOND V HURET JL GIRAUD C TANZER J ECLACHE V CAPODANO AM ZATTARACANNONI H LEONARD C TCHERNIA G
Citation: C. Charrin et al., CYTOGENETIC ABNORMALITIES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATIONS WITH HEMATOLOGIC FINDINGS AND OUTCOME - A COLLABORATIVE STUDY OF THE GROUPE-FRANCAIS-DE-CYTOGENETIQUE-HEMATOLOGIQUE, Blood, 87(8), 1996, pp. 3135-3142
EXPRESSION AND LONG-TERM PROGNOSTIC VALUE OF CD34 IN CHILDHOOD AND ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: VANHAEKE DR BENE MC GARAND R FAURE GC GARDAIS J LEGLISE MC LECALVEZ G BERNIER M MASSY M GRIVEAU AM BROUTARD P LEBRUN C BONHOMME J CHASSAGNE B DEMEOCQ F RAPATEL C TAVERNIER F JOUAULT H LELONG F CHRETIEN P SOLARY E CASASNOVAS RO MAYNADIE M BENSA JC FAVRE M JACOB MC SARTIAUX C HUART JL DROUET M PRALORAN V TRIMOREAU F CAMPOS L LARESE A PONCELET P BESSONFAURE I BRUNET C LAVABREBERTRAND T TAIB J KANDEL G JUNG G HARROUSSEAU JL PHILIP P MONPOUX F BAUDOUIN F SUDAKA I CALDANI C VANHAEKE D BERNARD A VALENSI F BOURIN P ARBORIO M SCHAISON G BOUMSELL L ADAM M DOUAI L BRIZARD A DALIPHARD S GENETET N FAUCHET R DRENOU B LEES O LENORMAND B VANNIER JP SABIDO O GUYOTAT D VASSELON C FALKENRODT A ALBERT A BREMOND JL GEORGET MT KUHLEIN E LEBARON F DUTHILLEUL P REUMAUX F FAURE G KOLOPPSARDA MN BORDIGONI P WITZ F BAYLE C ANTONINI J CHARPENTIER A
Citation: Dr. Vanhaeke et al., EXPRESSION AND LONG-TERM PROGNOSTIC VALUE OF CD34 IN CHILDHOOD AND ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia & lymphoma, 20(1-2), 1995, pp. 137-142
A COMPARISON OF OUTCOME AFTER BONE-MARROW TRANSPLANTATION USING UNRELATED OR AUTOLOGOUS BONE-MARROW IN PATIENTS WITH ACUTE-LEUKEMIA
Authors: RINGDEN O LABOPIN M GLUCKMAN E JACOBSEN N VERNANT JP BOOGAERTZ M WITZ F HAROSSEAU JL GORIN NC
Citation: O. Ringden et al., A COMPARISON OF OUTCOME AFTER BONE-MARROW TRANSPLANTATION USING UNRELATED OR AUTOLOGOUS BONE-MARROW IN PATIENTS WITH ACUTE-LEUKEMIA, Experimental hematology, 23(8), 1995, pp. 939-939
DRUG-INDUCED AGRANULOCYTOSIS - CLINICAL-S TUDY ABOUT 30 PATIENTS AND ETIOLOGIC EVOLUTION BETWEEN 2 DECADES
Authors: PAITEL JF STOCKEMER V DORVAUX V WITZ F GUERCI A LEDERLIN P
Citation: Jf. Paitel et al., DRUG-INDUCED AGRANULOCYTOSIS - CLINICAL-S TUDY ABOUT 30 PATIENTS AND ETIOLOGIC EVOLUTION BETWEEN 2 DECADES, La Revue de medecine interne, 16(7), 1995, pp. 495-499
Risultati: 1-25 | 26-42